shutterstock_1532109092_sundry_photography

Sundry Photography / Shutterstock.com

25 March 2021AmericasMuireann Bolger

Abbott unit prevails in dispute over catheter patent

In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing (NLC).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

St Jude recovers partial attorney fees in heart catheter case

26 October 2021 St Jude Medical will be able to claw back some of the attorney fees and expenses it incurred defending a suit filed by Niazi Licensing Corporation in a dispute over a patent covering a heart catheter.

Glycosyn sues Abbott over infant formula method

16 June 2022 Biotech company Glycosyn has sued Abbott Laboratories for allegedly infringing its patented method for manufacturing a key ingredient in infant formula milk, found in three of Abbott’s infant formula products under the Similac brand.

Abbott secures $26m damages in TM clash

4 January 2023 Distributors and pharmacies face millions in damages and costs after selling international versions of Abbott products in the US | Fraud upon the court discovered after a court-authorised search of defendant’s premises seized an email server.

More on this story

Abbott secures $26m damages in TM clash

4 January 2023 Distributors and pharmacies face millions in damages and costs after selling international versions of Abbott products in the US | Fraud upon the court discovered after a court-authorised search of defendant’s premises seized an email server.

Glycosyn sues Abbott over infant formula method

16 June 2022 Biotech company Glycosyn has sued Abbott Laboratories for allegedly infringing its patented method for manufacturing a key ingredient in infant formula milk, found in three of Abbott’s infant formula products under the Similac brand.

St Jude recovers partial attorney fees in heart catheter case

26 October 2021 St Jude Medical will be able to claw back some of the attorney fees and expenses it incurred defending a suit filed by Niazi Licensing Corporation in a dispute over a patent covering a heart catheter.

More on this story

Abbott secures $26m damages in TM clash

4 January 2023 Distributors and pharmacies face millions in damages and costs after selling international versions of Abbott products in the US | Fraud upon the court discovered after a court-authorised search of defendant’s premises seized an email server.

Glycosyn sues Abbott over infant formula method

16 June 2022 Biotech company Glycosyn has sued Abbott Laboratories for allegedly infringing its patented method for manufacturing a key ingredient in infant formula milk, found in three of Abbott’s infant formula products under the Similac brand.

St Jude recovers partial attorney fees in heart catheter case

26 October 2021 St Jude Medical will be able to claw back some of the attorney fees and expenses it incurred defending a suit filed by Niazi Licensing Corporation in a dispute over a patent covering a heart catheter.

More features

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?

Pfizer infringed haemophilia therapy patent, says court